Follow Us:
Sugammadex Exporter From India

Sugammadex

Sugammadex is a selective neuromuscular blocking agent reversal drug used to reverse muscle relaxation caused by rocuronium and vecuronium during general anaesthesia. It acts by selectively binding to these steroidal neuromuscular blocking agents in the blood, forming stable complexes that reduce their free concentration and allow them to move away from nicotinic receptors at the neuromuscular junction. This restores normal neuromuscular transmission and skeletal muscle function. It is administered intravenously under medical supervision, usually at the end of surgery. Common side effects include nausea, vomiting, headache and pain. Serious adverse effects may include anaphylaxis, severe bradycardia and marked hypotension. Respiratory and neuromuscular functions should be carefully monitored after administration to ensure complete recovery.

  • Dosage Form:
  • Dosage Strength:
  • Manufacturer:
  • CAS No.:
  • Status:

Applications of Sugammadex

Sugammadex was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:

is okay

Contraindication of Sugammadex

Availability of Sugammadex

Delivery of Sugammadex

Frequently Asked Questions

The most frequently asked questions focus on import, export, documentations, and regulation for Sugammadex.

The is a pharmaceutical active pharmaceutical ingredient (API) used in manufacturing of Sugammadex.

: Provides active pharmaceutical ingredients (APIs), customized production, and OEM/ODM services with research and technical cooperation across Europe, the USA, and India via Primeera Healthcare.

  • Therapeutic Goods Administration (TGA):
  • US Food and Drug Administration (USFDA):
  • European Medicines Agency (EMA):
  • African Medicines Agency (AMA):
  • National Medical Products Administration (NMPA):
  • Central Drugs Standard Control Organization (CDSCO):

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Sugammadex, subject to confirmation of its current regulatory status and eligibility for import into India.

Documentation Required for Sugammadex Import

The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.

Import Regulations and dcoumentation for Sugammadex

  • Import Documentation Assistance:
    Support with organising commercial invoices, packing lists, manufacturer details, product specifications, certificates of analysis, and other relevant documents required for regulatory review and customs processing.

  • Regulatory Coordination:
    Assistance with identifying applicable CDSCO requirements, import authorisations, and documentation procedures, subject to the product's regulatory status and the proposed import route.
  • Shipping and Customs Coordination:
    Coordination with relevant logistics providers and customs professionals to organise shipment documentation and facilitate clearance where legally permitted.
  • Compliance Verification:
    Preliminary review of available product and shipment documentation to identify potential regulatory gaps before procurement or dispatch. Import arrangements will proceed only after the applicable permissions and restrictions have been verified.

Customs Clearance and Compliance Handling of Sugammadex Import

Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Sugammadex, subject to confirmation of its current regulatory status and eligibility for import into India.

Export Regulations and dcoumentation for Sugammadex

The export of Sugammadex from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.

Documentation Required for Sugammadex Emport

  • Export Documentation Assistance:
    Assistance with organising commercial invoices, packing lists, manufacturer details, Sugammadex specifications, certificates of analysis, and other supporting documents required for Sugammadex export and customs processing.
  • Regulatory Coordination:
    Support in identifying applicable country specific Sugammadex export requirements, relevant manufacturing and export authorisations, and destination-country registration or import approval requirements, subject to the Sugammadex regulatory status.
  • Shipping and Customs Coordination:
    Coordination with logistics providers, freight forwarders, and customs professionals to organise shipping documentation, export declarations, and customs clearance procedures where legally permitted.
  • Compliance Verification:
    Preliminary review of available Sugammadex documentation, labelling, Sugammadex manufacturing information, and destination-market requirements to identify potential regulatory gaps before dispatch. Export arrangements will proceed only after the applicable restrictions and authorisations have been verified.

Customs Clearance and Compliance Handling of Sugammadex Export

Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Sugammadex, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.

Product Export Support

If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.

Email Us

info@primeerahealthcare.com

Call Us

+(123) 456 789 00

Follow Us

Primeera Healthcare

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.